METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is characterized by its insensitivity to chemoradiotherapy and lacks effective diagnostic and prognostic biomarkers. In this study, we focused on the role of m6A RNA methylation regulators for tumor immunity. Based on the expression of 20 m6A regulators, conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tianbo, Gao, Su, Ruan, Hailong, Liu, Jingchong, Liu, Yuenan, Liu, Di, Tong, Junwei, Shi, Jian, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194313/
https://www.ncbi.nlm.nih.gov/pubmed/34122497
http://dx.doi.org/10.3389/fgene.2021.609174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194313/
https://www.ncbi.nlm.nih.gov/pubmed/34122497
http://dx.doi.org/10.3389/fgene.2021.609174

Ejemplares similares